Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41
Open accessAbstract
Short chain fatty acid (SCFA) metabolites are byproducts of gut microbial metabolism that are known to affect host physiology via host G protein-coupled receptor (GPCRs). We previously showed that an acute SCFA bolus decreases blood pressure (BP) in anesthetized mice, an effect mediated primarily via Gpr41. In this study, our aims were to identify the cellular localization of Gpr41 and to determine its role in BP regulation. We localized Gpr41 to the vascular endothelium using RT-PCR: Gpr41 is detected in intact vessels (with endothelium) but is absent from denuded vessels (without endothelium). Furthermore, using pressure myography we confirmed that SCFAs dilate resistance vessels in an endothelium-dependent manner. Since we previously found that Gpr41 mediates a hypotensive response to acute SCFA administration, we hypothesized that Gpr41 knockout (KO) mice would be hypertensive. Here, we report that Gpr41 KO mice have isolated systolic hypertension compared with wild-type (WT) mice; diastolic BP was not different between WT and KO. Older Gpr41 KO mice also exhibited elevated pulse wave velocity, consistent with a phenotype of systolic hypertension; however, there was no increase in ex vivo aorta stiffness (measured by mechanical tensile testing). Plasma renin concentrations were also similar in KO and WT mice. The systolic hypertension in Gpr41 KO is not salt sensitive, as it is not significantly altered on either a high- or low-salt diet. In sum, these studies suggest that endothelial Gpr41 lowers baseline BP, likely by decreasing active vascular tone without altering passive characteristics of the blood vessels, and that Gpr41 KO mice have hypertension of a vascular origin.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Olfr78 and Gpr41 participate in host blood pressure regulation.
“Early mechanistic studies by Pluznick and colleagues substantiated this idea by demonstrating the G-protein coupled SCFA receptors olfactory receptor 78 (Olfr78) and G-protein receptor 41 (Gpr41) participate in host blood pressure regulation59–61.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [61]
Interventions that target the gut microbiota, such as a high-fibre diet, probiotics and antibiotics, have blood-pressure lowering effects in animal models and in patients with hypertension.
“Finally, studies in animal models and in patients with hypertension have reported that interventions that target the gut microbiota, such as a high-fibre diet, probiotics and antibiotics, have blood-pressure lowering effects87,92–99.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [94]
Administration of propionate modulates blood pressure in mice, likely via binding to G protein-coupled receptor 41 and olfactory receptor 78.
“Administration of propionate has also been reported to modulate blood pressure in mice, likely via binding to the G protein-coupled receptor 41 (GPR41) and olfactory receptor 78 (OLFR78; also known as OR51E2)93,94.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · see citing works
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820 · see citing works
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · see citing works
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · see citing works
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · see citing works
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588 · see citing works
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409 · see citing works
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2014) · Cell · doi:10.1016/j.cell.2013.12.016 · Cited by 2,200 · see citing works
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000445171 · Cited by 1,925 · see citing works
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854 · see citing works
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651 · see citing works
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564 · see citing works
Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2852 · Cited by 1,512 · see citing works
Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
Perry, R. J., Peng, L., Barry, N. A., Cline, G. W., Zhang, D., Cardone, R. L., Petersen, K. F., Kibbey, R. G., Goodman, A. L., & Shulman, G. I. (2016) · Nature · doi:10.1038/nature18309 · Cited by 1,299 · see citing works
Pluznick, J. L., Protzko, R. J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., Brunet, I., Wan, L.-X., Rey, F., Wang, T., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215927110 · Cited by 1,191 · see citing works
Self-citationKimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobayashi, M., Hirasawa, A., & Tsujimoto, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016088108 · Cited by 1,106 · see citing works
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979 · see citing works
de La Serre, C. B., Ellis, C. L., Lee, J., Hartman, A. L., Rutledge, J. C., & Raybould, H. E. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2010 · Cited by 949 · see citing works
Perspectives on systolic hypertension. The Framingham study.
Kannel, W. B., Dawber, T. R., & McGee, D. L. (1980) · Circulation · doi:10.1161/01.cir.61.6.1179 · Cited by 461 · see citing works
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Moloney, R. D., Johnson, A. C., O’Mahony, S. M., Dinan, T. G., Meerveld, B. G., & Cryan, J. F. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12490 · Cited by 396 · see citing works
Expression of short-chain fatty acid receptor GPR41 in the human colon
Tazoe, H., Otomo, Y., Karaki, S.-I., Kato, I., Fukami, Y., TERASAKI, M., & Kuwahara, A. (2009) · Biomedical Research · doi:10.2220/biomedres.30.149 · Cited by 330 · see citing works
Silent α2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries
Chotani, M. A., Flavahan, S., Mitra, S., Daunt, D. A., & Flavahan, N. A. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1075 · Cited by 274 · see citing works
Self-citationNitric Oxide and the Regulation of Large Artery Stiffness
Wilkinson, I. B., Franklin, S. S., & Cockcroft, J. R. (2004) · Hypertension · doi:10.1161/01.hyp.0000138068.03893.40 · Cited by 274 · see citing works
Genetic and Molecular Aspects of Hypertension
Padmanabhan, S., Caulfield, M. J., & Dominiczak, A. F. (2015) · Circulation Research · doi:10.1161/circresaha.116.303647 · Cited by 274 · see citing works
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
Ulven, T. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00111 · Cited by 272 · see citing works
Short-Chain Fatty Acids in Germfree Mice and Rats
Høverstad, T., & Midtvedt, T. (1986) · Journal of Nutrition · doi:10.1093/jn/116.9.1772 · Cited by 256 · see citing works
Endothelium‐derived relaxing and contracting factors
Rubanyi, G. M. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240460106 · Cited by 231 · see citing works
Short chain fatty acids dilate isolated human colonic resistance arteries.
Mortensen, F. V., Nielsen, H. K., Mulvany, M. J., & Hessov, I. (1990) · Gut · doi:10.1136/gut.31.12.1391 · Cited by 197 · see citing works
Won, Y., Lu, V. B., Puhl, H. L., & Ikeda, S. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3102-13.2013 · Cited by 160 · see citing works
Hartner, A. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg299 · Cited by 138 · see citing works
Sykaras, A. G., Demenis, C., CASE, R. M., McLaughlin, J. T., & Smith, C. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042373 · Cited by 122 · see citing works
Renal and cardiovascular sensory receptors and blood pressure regulation
Pluznick, J. L. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00252.2013 · Cited by 120 · see citing works
Self-citationChatterjee, S. B., Bedja, D., Mishra, S., Amuzie, C., Avolio, A. P., Kass, D. A., Berkowitz, D. E., & Renehan, M. (2014) · Circulation · doi:10.1161/circulationaha.113.007559 · Cited by 109 · see citing works
Self-citationInoue, D., Kimura, I., Wakabayashi, M., Tsumoto, H., Ozawa, K., Hara, T., Takei, Y., Hirasawa, A., Ishihama, Y., & Tsujimoto, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.021 · Cited by 99 · see citing works
Vasorelaxant effects of short chain fatty acid salts in rat caudal artery
Nutting, C. W., Islam, S., & Daugirdas, J. T. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.2.h561 · Cited by 99 · see citing works
Redox Signaling of the Arteriolar Myogenic Response
Nowicki, P. T., Flavahan, S., Hassanain, H. H., Mitra, S., Holland, S. M., Goldschmidt‐Clermont, P. J., & Flavahan, N. A. (2001) · Circulation Research · doi:10.1161/hh1401.094367 · Cited by 98 · see citing works
Self-citationAcetylcholine causes endothelium-dependent contraction of mouse arteries
Zhou, Y., Varadharaj, S., Zhao, X., Parinandi, N. L., Flavahan, N. A., & Zweier, J. L. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00226.2005 · Cited by 96 · see citing works
Self-citationShort-chain fatty acid formation at fermentation of indigestible carbohydrates
Henningsson, Å. M., Björck, I., & NYMAN, M. E. (2001) · Näringsforskning · doi:10.3402/fnr.v45i0.1801 · Cited by 84 · see citing works
Exercise, Vascular Stiffness, and Tissue Transglutaminase
Steppan, J., Sikka, G., Jandu, S. K., Barodka, V. M., Halushka, M. K., Flavahan, N. A., Belkin, A. M., Nyhan, D. P., Butlin, M., Avolio, A. P., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000599 · Cited by 76 · see citing works
Self-citationOverexpression of Renin in the Collecting Duct Causes Elevated Blood Pressure
Ramkumar, N., Ying, J., Stuart, D., & Kohan, D. E. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt071 · Cited by 46 · see citing works
Knock, G. A., Psaroudakis, D., Abbot, S. E., & Aaronson, P. I. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013105 · Cited by 29 · see citing works
Hosseini, A., Behrendt, C., Regenhard, P., Sauerwein, H., & Mielenz, M. (2011) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2011.01180.x · Cited by 25 · see citing works
Renin dependency of blood pressure in isolated systolic hypertension
Niarchos, A. P., & Laragh, J. H. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90091-3 · Cited by 24 · see citing works
Olfaction in the kidney: ‘smelling’ gut microbial metabolites
Natarajan, N., & Pluznick, J. L. (2015) · Experimental Physiology · doi:10.1113/ep085285 · Cited by 24 · see citing works
Self-citationEffects of diuretic therapy in low-, normal- and high-benin isolated systolic systemic hypertension
Niarchos, A. P., & Laragh, J. H. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90407-7 · Cited by 22 · see citing works
Short chained fatty acids and the colon: how do they cause vasodilatation?
Aalkjær, C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.015115 · Cited by 9 · see citing works
Durukan, M. K., Güray, Ü., Aksu, T., Guray, Y. A., Demirkan, B., & Korkmaz, Ş. (2012) · Blood Pressure · doi:10.3109/08037051.2012.686167 · Cited by 7 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [37]Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, NY) : 569–573, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
Fusco, W. G., Bernabeu, M., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M. C., Gasbarrini, A., Collado, M. C., et al. (2023) · Nutrients · doi:10.3390/nu15092211 · Cited by 1,318 · see citing works
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051 · see citing works
Nogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917 · see citing works
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036652 · Cited by 822 · see citing works
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753 · see citing works
Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691 · see citing works
Intestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 508 · see citing works
Gut microbiota derived metabolites in cardiovascular health and disease
Wang, Z., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0549-0 · Cited by 475 · see citing works
Beyond gut feelings: how the gut microbiota regulates blood pressure
Marques, F. Z., Mackay, C. R., & Kaye, D. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.120 · Cited by 400 · see citing works
Haghikia, A., Zimmermann, F., Schumann, P., Jasina, A., Roessler, J., Schmidt, D., Heinze, P., Kaisler, J., Nageswaran, V., Aigner, A., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab644 · Cited by 376 · see citing works
The mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · FEBS Journal · doi:10.1111/febs.15217 · Cited by 331 · see citing works
Microbial Short-Chain Fatty Acids and Blood Pressure Regulation
Pluznick, J. L. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0722-5 · Cited by 301 · see citing works
Self-citationFlavonoids, Dairy Foods, and Cardiovascular and Metabolic Health
Mozaffarian, D., & Wu, J. H. Y. (2018) · Circulation Research · doi:10.1161/circresaha.117.309008 · Cited by 305 · see citing works
The gut microbiome and hypertension
O’Donnell, J. A., Zheng, T., Méric, G., & Marques, F. Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00654-0 · Cited by 294 · see citing works
Dietary Fibers from Fruits and Vegetables and Their Health Benefits via Modulation of Gut Microbiota
Cui, J., Lian, Y., Zhao, C., Du, H., Han, Y., Gao, W. Y., Xiao, H., & Zheng, J. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12489 · Cited by 243 · see citing works
Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease
Cong, J., Zhou, P., & Zhang, R. (2022) · Nutrients · doi:10.3390/nu14091977 · Cited by 234 · see citing works
Deehan, E. C., Duar, R. M., Armet, A. M., Pérez-Muñoz, M. E., Jin, M., & Walter, J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0019-2017 · Cited by 227 · see citing works
Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13010144 · Cited by 232 · see citing works
The Role of Gut Microbiota in Atherosclerosis and Hypertension
Ma, J., & Li, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01082 · Cited by 226 · see citing works
Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study
Calderón-Pérez, L., Gosalbes, M. J., Yuste, S., Valls, R. M., Pedret, A., Llauradó, E., Jiménez‐Hernández, N., Artacho, A., Pla‐Pagà, L., Companys, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63475-w · Cited by 224 · see citing works
Toral, M., Robles‐Vera, I., de la Visitación, N., Romero, M., Yang, T., Sánchez, M., Gómez‐Guzmán, M., Jiménez, R., Raizada, M. K., & Duarte, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00231 · Cited by 223 · see citing works
Tan, C., Wu, Q., Wang, H., Gao, X., Xu, R., Cui, Z., Zhu, J., Zeng, X., Zhou, H., He, Y., et al. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1861 · Cited by 229 · see citing works
Konopelski, P., & Mogilnicka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031222 · Cited by 218 · see citing works
Malik, M. A., Suboc, T. M. B., Tyagi, S., Salzman, N. H., Wang, J., Ying, R., Tanner, M. J., Kakarla, M., Baker, J. E., & Widlansky, M. E. (2018) · Circulation Research · doi:10.1161/circresaha.118.313565 · Cited by 218 · see citing works
Sánchez-Rodríguez, E., Egea-Zorrilla, A., Plaza‐Díaz, J., Aragón‐Vela, J., Muñoz‐Quezada, S., Tercedor‐Sánchez, L., & Abadía‐Molina, F. (2020) · Nutrients · doi:10.3390/nu12030605 · Cited by 220 · see citing works
Li, X., Watanabe, K., & Kimura, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01882 · Cited by 209 · see citing works
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Brial, F., Lay, A. L., Dumas, M., & Gauguier, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2901-1 · Cited by 197 · see citing works
Ge, X., Zheng, L., Zhuang, R., Yu, P., Xu, Z., Liu, G., Xi, X., Zhou, X., & Fan, H. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz064 · Cited by 195 · see citing works
Zanoli, L., Briet, M. B., Empana, J. P., Cunha, P., Maki-Petaja, K. M., Protogerou, A. D., Tedgui, A., Touyz, R. M., Schiffrin, E. L., Spronck, B., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002508 · Cited by 194 · see citing works
Ganesh, B. P., Nelson, J. W., Eskew, J. R., Ganesan, A., Ajami, N. J., Petrosino, J. F., Bryan, R. M., & Durgan, D. J. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11695 · Cited by 190 · see citing works
Gut microbiome and its role in cardiovascular diseases
Ahmadmehrabi, S., & Tang, W. H. W. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000445 · Cited by 185 · see citing works
Short-chain fatty acid, acylation and cardiovascular diseases
Chen, X., Chen, X., & Tang, X. (2020) · Clinical Science · doi:10.1042/cs20200128 · Cited by 186 · see citing works
The gut microbiota as a novel regulator of cardiovascular function and disease
Battson, M. L., Lee, D. M., Weir, T. L., & Gentile, C. L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.010 · Cited by 185 · see citing works
Felizardo, R. J. F., Watanabe, I. K. M., Dardi, P., Rossoni, L. V., & Câmara, N. O. S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.019 · Cited by 176 · see citing works
The oral microbiome in the pathophysiology of cardiovascular disease
Tonelli, A., Lumngwena, E. N., & Ntusi, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00825-3 · Cited by 181 · see citing works
The Gut Microbiome in Hypertension
Avery, E. G., Bartolomaeus, H., Maifeld, A., Markó, L., Wiig, H., Wilck, N., Rosshart, S. P., Forslund, S. K., & Müller, D. N. (2021) · Circulation Research · doi:10.1161/circresaha.121.318065 · Cited by 174 · see citing works
Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects
Rekha, K., Venkidasamy, B., Samynathan, R., Nagella, P., Ребезов, М. Б., Khayrullin, M., Ponomarev, E., Bouyahya, A., Sarkar, T., Shariati, M. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2124231 · Cited by 166 · see citing works
GPR41 and GPR43: From development to metabolic regulation
Lee, D., Kim, M.-T., & Han, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116735 · Cited by 160 · see citing works
Differential Analysis of Hypertension-Associated Intestinal Microbiota
Dan, X., Mushi, Z., Baili, W., Han, L., Enqi, W., Huanhu, Z., & Li, S. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.29322 · Cited by 157 · see citing works
Amiri, P., Hosseini, S. A., Ghaffari, S., Tutunchi, H., Ghaffari, S., Mosharkesh, E., Asghari, S., & Roshanravan, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.837509 · Cited by 155 · see citing works
Kanbay, M., Onal, E. M., Afşar, B., Dağel, T., Yerlikaya, A., Covic, A. C., & Vaziri, N. D. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1873-2 · Cited by 154 · see citing works
Sex, gut microbiome, and cardiovascular disease risk
Razavi, A. C., Potts, K. S., Kelly, T. N., & Bazzano, L. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0240-z · Cited by 151 · see citing works
Carrillo-Salinas, F. J., Anastasiou, M., Ngwenyama, N., Kaur, K., Tai, A., Smolgovsky, S. A., Jetton, D., Aronovitz, M. J., & Alcaide, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1823801 · Cited by 144 · see citing works
Yan, J., Pan, Y., Shao, W., Wang, C., Wang, R., He, Y., Zhang, M., Wang, Y., Li, T., Wang, Z., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01390-0 · Cited by 148 · see citing works
Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke
Wu, H., & Chiou, J. A. (2021) · Nutrients · doi:10.3390/nu13082878 · Cited by 147 · see citing works
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Jin, L., Shi, X., Yang, J., Zhao, Y., Xue, L., Xu, L., & Cai, J. (2020) · Protein & Cell · doi:10.1007/s13238-020-00785-9 · Cited by 143 · see citing works
Cardiac metabolism in HFpEF: from fuel to signalling
Capone, F., Sotomayor-Flores, C., Bode, D., Wang, R., Rodolico, D., Strocchi, S., & Schiattarella, G. G. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac166 · Cited by 141 · see citing works
Mishra, S. P., Karunakar, P., Taraphder, S., & Yadav, H. (2020) · Biomedicines · doi:10.3390/biomedicines8060154 · Cited by 139 · see citing works
Muralitharan, R. R., Jama, H. A., Xie, L., Peh, A., Snelson, M., & Marques, F. Z. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14473 · Cited by 131 · see citing works
Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
Yang, F., Chen, H., Gao, Y., An, N., Li, X., Pan, X., Yang, X., Tian, L., Sun, J., Xiong, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110503 · Cited by 131 · see citing works
Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension
Zubcevic, J. A., Richards, E. M., Yang, T., Kim, S., Sumners, C., Pepine, C. J., & Raizada, M. K. (2019) · Circulation Research · doi:10.1161/circresaha.119.313965 · Cited by 123 · see citing works
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 124 · see citing works
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 121 · see citing works
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 122 · see citing works
Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives
Chen, L., He, F. J., Dong, Y., Huang, Y., Wang, C., Harshfield, G. A., & Zhu, H. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14800 · Cited by 116 · see citing works
Salt Sensitivity: Causes, Consequences, and Recent Advances
Bailey, M. A., & Dhaun, N. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.17959 · Cited by 121 · see citing works
Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II
Robles‐Vera, I., Toral, M., de la Visitación, N., Aguilera-Sánchez, N., Redondo, J. M., & Duarte, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00277 · Cited by 118 · see citing works
Gut Microbiome and Neuroinflammation in Hypertension
Richards, E. M., Li, J., Stevens, B. R., Pepine, C. J., & Raizada, M. K. (2022) · Circulation Research · doi:10.1161/circresaha.121.319816 · Cited by 114 · see citing works
FFAR2‐FFAR3 receptor heteromerization modulates short‐chain fatty acid sensing
Ang, Z., Xiong, D., Wu, M., & Ding, J. L. (2017) · The FASEB Journal · doi:10.1096/fj.201700252rr · Cited by 108 · see citing works
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Wu, Y., Xu, H., Tu, X., & Gao, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.730809 · Cited by 108 · see citing works
Xu, J., Moore, B. N., & Pluznick, J. L. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18558 · Cited by 110 · see citing works
Self-citationMarzocco, S., Fazeli, G., Micco, L. D., Autore, G., Adesso, S., Piaz, F. D., Heidland, A., & Iorio, B. R. D. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100315 · Cited by 107 · see citing works
Onal, E. M., Afşar, B., Covic, A. C., Vaziri, N. D., & Kanbay, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0144-z · Cited by 106 · see citing works
Short-Chain Fatty Acid Receptors and Cardiovascular Function
Lymperopoulos, A., Suster, M. S., & Borges, J. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063303 · Cited by 106 · see citing works
Jama, H. A., Beale, A. L., Shihata, W., & Marques, F. Z. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz091 · Cited by 102 · see citing works
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
Lu, Y., Zhang, Y., Zhao, X., Shang, C., Xiang, M., Li, L., & Cui, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.900381 · Cited by 109 · see citing works
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Snelson, M., Muralitharan, R. R., Liu, C., Markó, L., Forslund, S. K., Marques, F. Z., & Tang, W. H. W. (2025) · Circulation Research · doi:10.1161/circresaha.125.325516 · Cited by 106 · see citing works
Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
D’Haens, G., & Jobin, C. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.053 · Cited by 98 · see citing works
The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
Chi, M., Ma, K., Wang, J., Ding, Z., Li, Y., Zhu, S., Liang, X., Zhang, Q., Song, L., & Liu, C. (2021) · Journal of Immunology Research · doi:10.1155/2021/5516035 · Cited by 98 · see citing works
Cheema, M. U., & Pluznick, J. L. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13155 · Cited by 97 · see citing works
Self-citationImportance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)
Hemmati, M., Kashanipoor, S., Mazaheri, P., Alibabaei, F., Babaeizad, A., Asli, S., Mohammadi, S., Gorgin, A. H., Ghods, K., Yousefi, B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121947 · Cited by 102 · see citing works
Diet-gut microbiota interactions on cardiovascular disease
Zhang, X., & Gérard, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.028 · Cited by 94 · see citing works
Mueller, N. T., Zhang, M., Juraschek, S. P., Miller, E. R., & Appel, L. J. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz322 · Cited by 94 · see citing works
A cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 95 · see citing works
Disparate effects of antibiotics on hypertension
Galla, S., Chakraborty, S., Cheng, X., Yeo, J., Mell, B., Zhang, H. Y., Mathew, A. V., Vijay–Kumar, M., & Joe, B. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00073.2018 · Cited by 84 · see citing works
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Sircana, A., Michieli, F. D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Paschetta, E., Bongiovanni, D., & Musso, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.013 · Cited by 86 · see citing works
Gut Microbiota Metabolites Sensed by Host GPR41/43 Protect Against Hypertension
Muralitharan, R. R., Zheng, T., Dinakis, E., Xie, L., Barbaro-Wahl, A., Jama, H. A., Nakai, M. E., Patterson, M., Leung, K. C., McArdle, Z. M., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325770 · Cited by 88 · see citing works
Obstructive Sleep Apnea and Systemic Hypertension: Gut Dysbiosis as the Mediator?
Mashaqi, S., & Gozal, D. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7990 · Cited by 81 · see citing works
Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO
Poll, B. G., Cheema, M. U., & Pluznick, J. L. (2020) · Physiology · doi:10.1152/physiol.00004.2020 · Cited by 84 · see citing works
Self-citationMicrobiota-derived tryptophan metabolism: Impacts on health, aging, and disease
Gupta, S. K., Vyavahare, S. S., Blanes, I. L. D., Berger, F. G., Isales, C. M., & Fulzele, S. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112319 · Cited by 85 · see citing works
Carnagarin, R., Matthews, V. B., Zaldivia, M. T. K., Peter, K., & Schlaich, M. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14481 · Cited by 82 · see citing works
The gut–kidney–heart axis in chronic kidney disease
Sumida, K., & Kovesdy, C. P. (2019) · Physiology International · doi:10.1556/2060.106.2019.19 · Cited by 79 · see citing works
Poll, B. G., Xu, J., Jun, S., Sanchez, J., Zaidman, N. A., He, X., Lester, L., Berkowitz, D. E., Paolocci, N., Gao, W. D., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000187 · Cited by 75 · see citing works
Self-citationHow Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure
Xu, C., & Marques, F. Z. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01216-2 · Cited by 75 · see citing works
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder
Chakraborty, S., Mandal, J., Yang, T., Cheng, X., Yeo, J., McCarthy, C. G., Wenceslau, C. F., Koch, L. G., Hill, J. W., Vijay–Kumar, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.13896 · Cited by 75 · see citing works
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 72 · see citing works
He, L., Prodhan, M. A. I., Yuan, F., Yin, X., Lorkiewicz, P. K., Wei, X., Feng, W., McClain, C. J., & Zhang, X. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.06.028 · Cited by 70 · see citing works
Xue, Y., Cui, L., Qi, J., Ojo, O., Du, X., Liu, Y., & Wang, X. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.04.013 · Cited by 67 · see citing works
In-vivo biotransformation of citrus functional components and their effects on health
Karn, A., Zhao, C., Yang, F., Cui, J., Gao, Z., Wang, M., Wang, F., Xiao, H., & Zheng, J. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1746234 · Cited by 66 · see citing works
Raizada, M. K., Joe, B., Bryan, N. S., Chang, E. B., Dewhirst, F. E., Borisy, G. G., Galis, Z. S., Henderson, W. A., José, P. A., Ketchum, C. J., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09699 · Cited by 65 · see citing works
Self-citationPolsinelli, V. B., Sinha, A., & Shah, S. J. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0370-8 · Cited by 64 · see citing works
Gough, E. K., Edens, T. J., Geum, H. M., Baharmand, I., Gill, S. K., Robertson, R. C., Mutasa, K., Ntozini, R., Smith, L. E., Chasekwa, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103421 · Cited by 65 · see citing works
New drug targets for hypertension: A literature review
Gao, Q., Xu, L., & Cai, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166037 · Cited by 62 · see citing works
The gut microbiota and blood pressure in experimental models
Jama, H. A., Kaye, D. M., & Marques, F. Z. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000476 · Cited by 62 · see citing works
Hsu, C., Hou, C., Chang‐Chien, G., Lin, S., Yang, H., & Tain, Y. (2020) · Biomedicines · doi:10.3390/biomedicines8120567 · Cited by 61 · see citing works
Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure
Iwashita, M., Nagatomo, Y., Kawai, A., Taruoka, A., Yumita, Y., Kagami, K., Yasuda, R., Toya, T., Ikegami, Y., Masaki, N., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111805 · Cited by 64 · see citing works
Yang, M., & Lao, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00158 · Cited by 60 · see citing works
Sodium, hypertension, and the gut: does the gut microbiota go salty?
Smiljanec, K., & Lennon, S. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2019 · Cited by 61 · see citing works
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 60 · see citing works
Walsh, J. J., Neudorf, H., & Little, J. P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa925 · Cited by 59 · see citing works
- Authors
- Natarajan, N., Hori, D., Flavahan, S., Steppan, J., Flavahan, N. A., Berkowitz, D. E., & Pluznick, J. L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pluznick, Jennifer L.
- ORCID
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2016-11-01
- Volume
- 48
- Issue
- 11
- Pages
- 826-834
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- PMC
- PMC6223570
- OpenAlex
- W2522093042
- Cited by
- 441
- References
- 47
- Citations by year
- 2026: 37 · 2025: 50 · 2024: 42 · 2023: 52 · 2022: 67 · 2021: 68 · 2020: 51 · 2019: 32 · 2018: 26 · 2017: 16
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Physiological Genomics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association (AHA) (14PRE20090006, 16IRG27260265)
- Japan Heart foundation
- HHS | National Institutes of Health (NIH) (R01HL12851, NIH R01DK107726)
- Hopkins Conte Digestive Diseases Basic and Traslational Research Core Center
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- short-chain fatty acids, GPR41, blood pressure regulation, systolic hypertension, gut microbiota, endothelium-dependent vasodilation, pulse wave velocity, aortic stiffness, plasma renin, salt sensitivity
- MeSH terms
- Animals, Bacteria, Blood Pressure, Endothelium, Vascular, Fatty Acids, Volatile, Female, Hypertension, Male, Mice, Inbred C57BL, Renin, Systole, Vasodilation, Sodium Chloride, Dietary, Mice, Knockout, Sus scrofa, Receptors, G-Protein-Coupled, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review